| Jul 25 |
Agilent to Acquire Canadian CDMO BIOVECTRA for $925 Million
|
| Jul 25 |
Agilent: Making A Move To Ignite Some Growth
|
| Jul 24 |
Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board
|
| Jul 23 |
Estimating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
|
| Jul 23 |
Agilent agrees to acquire BIOVECTRA for $925m
|
| Jul 22 |
Agilent (A) Boosts DCG Segment With New ProteoAnalyzer System
|
| Jul 22 |
Agilent to buy contract drug manufacturer Biovectra for $925 million
|
| Jul 22 |
Agilent to acquire North American CDMO BIOVECTRA for $925 million
|
| Jul 22 |
Agilent to Acquire North American CDMO BIOVECTRA
|
| Jul 22 |
Agilent Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit
|
